Evidence map›Paper›PMID 24658703›Full record

ArticlePloS one2014

Brown fat determination and development from muscle precursor cells by novel action of bone morphogenetic protein 6.

Ankur Sharma, Christine Huard, Cecile Vernochet, Daniel Ziemek, Kelly M Knowlton, Edyta Tyminski, Theresa Paradis, Ying Zhang, Jessica E C Jones, David von Schack and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Beyond the bone: Bone morphogenetic protein signaling in adipose tissue.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ankur SharmaCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Christine HuardCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Cecile VernochetCVMED, Pfizer Inc., Cambridge, Massachusetts, United States of America.
Daniel ZiemekComputational Sciences Center of Emphasis, Pfizer Inc, Cambridge, Massachusetts, United States of America.
Kelly M KnowltonCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Edyta TyminskiCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Theresa ParadisBioTherapeutics Clinical Research, Pfizer Inc., Cambridge, Massachusetts, United States of America.
Ying ZhangBioTherapeutics Clinical Research, Pfizer Inc., Cambridge, Massachusetts, United States of America.
Jessica E C JonesCVMED, Pfizer Inc., Cambridge, Massachusetts, United States of America.
David von SchackBioTherapeutics Clinical Research, Pfizer Inc., Cambridge, Massachusetts, United States of America.
Christopher T BrownGlobal BioTherapeutics Technologies, Pfizer Inc., Cambridge, Massachusetts, United States of America.
Patrice M MilosCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Anthony J CoyleCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Frederic TremblayCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Robert V MartinezCenters for Therapeutic Innovation, Pfizer Inc., Boston, Massachusetts, United States of America.
Pfizer (United States) · USTherapeutics Clinical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown adipose tissue (BAT) plays a pivotal role in promoting energy expenditure by the virtue of uncoupling protein-1 (UCP-1) that differentiates BAT from its energy storing white adipose tissue (WAT) counterpart. The clinical implication of "classical" BAT (originates from Myf5 positive myoblastic lineage) or the "beige" fat (originates through trans-differentiation of WAT) activation in improving metabolic parameters is now becoming apparent. However, the inducers and endogenous molecular determinants that govern the lineage commitment and differentiation of classical BAT remain obscure. We report here that in the absence of any forced gene expression, stimulation with bone morphogenetic protein 6 (BMP6) induces brown fat differentiation from skeletal muscle precursor cells of murine and human origins. Through a comprehensive transcriptional profiling approach, we have discovered that two days of BMP6 stimulation in C2C12 myoblast cells is sufficient to induce genes characteristic of brown preadipocytes. This developmental switch is modulated in part by newly identified regulators, Optineurin (Optn) and Cyclooxygenase-2 (Cox2). Furthermore, pathway analyses using the Causal Reasoning Engine (CRE) identified additional potential causal drivers of this BMP6 induced commitment switch. Subsequent analyses to decipher key pathway that facilitates terminal differentiation of these BMP6 primed cells identified a key role for Insulin Like Growth Factor-1 Receptor (IGF-1R). Collectively these data highlight a therapeutically innovative role for BMP6 by providing a means to enhance the amount of myogenic lineage derived brown fat.

Indexed as

AdipocytesAdipogenesisAdipose Tissue, BrownAnimalsBone Morphogenetic Protein 6Bone Morphogenetic Protein 7Cell Cycle ProteinsCell DifferentiationCell LineCluster AnalysisCyclooxygenase 2Fatty AcidsGene Expression ProfilingGene Expression RegulationGene Knockdown TechniquesHumansBone Morphogenetic Protein 6Bone Morphogenetic Protein 7Cell Cycle ProteinsCyclooxygenase 2Fatty AcidsIon ChannelsMembrane Transport ProteinsMitochondrial ProteinsOPTN protein, humanReceptor, IGF Type 1Transcription Factor TFIIIAUCP1 protein, humanUcp1 protein, mouseUncoupling Protein 1

Identifiers

PMID24658703
PMCPMC3962431
OpenAlexW2061322525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.